In vivo31P MR Spectroscopy of Breast Tumors: Preliminary Results.
10.3348/jkrs.1995.33.3.465
- Author:
Sang Seol JUNG
;
Kyung Sub SHINN
;
Tae Suk SUH
;
Hak Hee KIM
;
Bo Young CHOE
- Publication Type:Original Article
- MeSH:
Adenosine Triphosphate;
Breast Diseases;
Breast Neoplasms*;
Breast*;
Healthy Volunteers;
Humans;
Hydrogen-Ion Concentration;
Magnetic Resonance Spectroscopy*;
Phosphocreatine;
Phosphorus;
Spectrum Analysis
- From:Journal of the Korean Radiological Society
1995;33(3):465-470
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the various phosphorus metabolism' of breast tumors with use of in vivo phosphorus-31 (31P) M R spectroscopy (MRS) MATERIALS AND METHODS: Five patients with breast tumor (benign in two, malignant in three) and three normal healthy volunteers participated in this study. All in vivo31P MRS examinations were performed on 1.5 Twhole-body MRI/MRS system by using a Free Induction Decay (FID) pulse sequence. Tl-weighted MR images were used for localization of tumors. Peak areas for each phosphorus metabolite were measured using a Marquart algorithm. RESULTS: Breast carcinoma had a substantially larger phosphomonoester (PME) and a smaller phosphocreatine (PCr) peak intensity than normal breast tissue. This was reflected in the relatively higher PME/PCr ratio of breast carcinomas as well as phosphodiester (PDE)/PCr, inorganic phosphate (Pi)/PCr, and adenosine triphosphate (ATP)/PCr ratios, compared with normal controls. The mean pH value of breast tumor demonstrating the alkaline nature was higher than that of normal controls. Spectral patterns between benign breast disease and normal breast tissue were quite similar, and differentiation was not established. CONCLUSION: Our preliminary study suggests that in vivo 31P MRS is a noninvasive examination which may be useful in the early differentiation of malignant breast tumors from normal and benign conditions. However, normal control and benign conditions could not be characterized on the basis of the phosphorus metabolite ratios.
